We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Novel Immune Biomarker Distinguishes Respiratory Infections

By LabMedica International staff writers
Posted on 27 Jun 2017
Print article
Image: A colorized negative stained transmission electron micrograph (TEM) depicting influenza virus ultrastructural morphology (Photo courtesy of the CDC).
Image: A colorized negative stained transmission electron micrograph (TEM) depicting influenza virus ultrastructural morphology (Photo courtesy of the CDC).
A novel immune biomarker has been identified that discriminates between influenza and bacteria in patients with suspected respiratory infection.

Host response biomarkers can accurately distinguish between influenza and bacterial infection. However, published biomarkers require the measurement of many genes, thereby making it difficult to implement in clinical practice.

Investigators at the University of Sydney (Australia) sought to identify a single-gene biomarker with a high diagnostic accuracy equivalent to multi-gene biomarkers. Towards this end they combined an integrated genomic analysis of 1071 individuals with in vitro experiments using well-established infection models.

The investigators reported finding the single-gene biomarker, IFI27 (Interferon alpha-inducible protein 27), which had a high prediction accuracy (91%) equivalent to that obtained by multi-gene biomarkers. In vitro studies showed that IFI27 was upregulated by TLR7 (Toll-like receptor 7) in dendritic cells, antigen-presenting cells that responded to influenza virus rather than bacteria. In vivo studies confirmed that IFI27 was expressed in influenza patients but not in bacterial infection, as demonstrated in multiple patient cohorts.

In a large prospective study of patients presenting with undifferentiated respiratory illness (etiologies included viral, bacterial, and non-infectious conditions), IFI27 displayed 88% diagnostic accuracy and 90% specificity in discriminating between influenza and bacterial infections.

The biomarker IFI27 has been incorporated into the patented "High-risk Influenza Screen Test," which requires only a single drop of blood and a few hours to run on equipment already available in most pathology laboratories.

"By using the High-risk Influenza Screen Test we are eavesdropping on the immune system to pick up when the body first mounts a defense against a serious, life-threatening infection. The early warning means we have a greater chance to treat the patient's infection before it overwhelms them and potentially kills them," said first author Dr. Benjamin Tang, associate professor of intensive care medicine at the University of Sydney. "We can now test people during a pandemic, or outbreak of a new flu virus, to identify those who might be at greater risk of developing serious complications. The test works with any flu infection as it looks at how the body reacts rather than the strain or type of virus."

The study was published in the June 15, 2017, online edition of the journal European Respiratory Journal.

Related Links:
University of Sydney

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.